Cizzle Biotechnology Valuation
| CIZ Stock | 1.80 0.10 5.26% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Cizzle Biotechnology shows a prevailing Real Value of USD1.54 per share. The current price of the firm is USD1.8. Our model approximates the value of Cizzle Biotechnology from analyzing the firm fundamentals such as Shares Owned By Insiders of 43.65 %, current valuation of 6.32 M, and Return On Equity of -1.58 as well as examining its technical indicators and probability of bankruptcy.
Price Book 8.9862 | Enterprise Value 6.3 M | Enterprise Value Ebitda (8.62) | Price Sales 200.4826 |
Overvalued
Today
Please note that Cizzle Biotechnology's price fluctuation is dangerous at this time. Calculation of the real value of Cizzle Biotechnology is based on 3 months time horizon. Increasing Cizzle Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cizzle stock is determined by what a typical buyer is willing to pay for full or partial control of Cizzle Biotechnology Holdings. Since Cizzle Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cizzle Stock. However, Cizzle Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.8 | Real 1.54 | Hype 1.82 | Naive 1.83 |
The real value of Cizzle Stock, also known as its intrinsic value, is the underlying worth of Cizzle Biotechnology Company, which is reflected in its stock price. It is based on Cizzle Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cizzle Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cizzle Biotechnology Holdings helps investors to forecast how Cizzle stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cizzle Biotechnology more accurately as focusing exclusively on Cizzle Biotechnology's fundamentals will not take into account other important factors: Cizzle Biotechnology Cash |
|
Cizzle Biotechnology Total Value Analysis
Cizzle Biotechnology Holdings is currently forecasted to have takeover price of 6.32 M with market capitalization of 7.53 M, debt of 186 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cizzle Biotechnology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.32 M | 7.53 M | 186 K |
Cizzle Biotechnology Asset Utilization
One of the ways to look at asset utilization of Cizzle is to check how much profit was generated for every dollar of assets it reports. Cizzle Biotechnology Holdings shows a negative utilization of assets of -0.32 percent, losing USD0.003172 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cizzle Biotechnology Holdings shows how discouraging it operates for each dollar spent on its assets.Cizzle Biotechnology Ownership Allocation
Cizzle Biotechnology holds a total of 396.39 Million outstanding shares. Cizzle Biotechnology Holdings retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cizzle Biotechnology Profitability Analysis
Net Loss for the year was (1.76 M) with profit before overhead, payroll, taxes, and interest of 25 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cizzle Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cizzle Biotechnology and how it compares across the competition.
About Cizzle Biotechnology Valuation
The stock valuation mechanism determines Cizzle Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cizzle Biotechnology. We calculate exposure to Cizzle Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cizzle Biotechnology's related companies.Complementary Tools for Cizzle Stock analysis
When running Cizzle Biotechnology's price analysis, check to measure Cizzle Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cizzle Biotechnology is operating at the current time. Most of Cizzle Biotechnology's value examination focuses on studying past and present price action to predict the probability of Cizzle Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cizzle Biotechnology's price. Additionally, you may evaluate how the addition of Cizzle Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |